Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

NCT03998033 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Reallocation of resources to new HCC study.

Conditions

Hepatocellular Carcinoma
Liver Cancer
Liver Neoplasm
Metastatic Liver Cancer

Interventions

BIOLOGICAL: ET140202 autologous T cell product

Sponsor

Eureka Therapeutics Inc.